Speakers

- B.A in Biotechnology at Tel Aviv University- 2015-2018- Fast-direct PhD excellence program at Tel Aviv University  2018-ongoingAs part of my PhD I study the field of systems immunology and begun studying the comprehensive temporal characterization of tumor-infiltrating B lymphocytes...

Samuel Azuz is a Clinical Pharmacologist MD and Senior Registrar at the Department of Clinical Pharmacology Aalborg University Hospital, Denmark. Member of the CLL and HIV expert committees, the Danish Medicines Council. Samuel's fields of interest include: Pharmacoeconomics, the biosimilar...

Dr George Badescu is Vice President Scientific Affairs at Heidelberg Pharma and has over 15 years of experience in the biotechnology sector. He most recently served as Vice President Scientific Affairs at Abzena Plc where he led the scientific promotion and commercialization of Abzena?s...

Alain Beck is Senior Director, Biologics CMC and developability, Pierre Fabre Laboratories (FR). He is associated editor of mAbs (USA) and mAbDesign advisor board chairman (www.mabdesign.fr). He has contributed to the R&D of immuno-oncology mAbs, clinical stages mAbs and ADCs in oncology...

Alun Bedding is currently the Global Head of Methods, Collaboration and Outreach in the Data and Statistical Sciences Department.  He has worked in the pharmaceutical industry for over 30 years and specializes in early clinical development, most specifically dose-finding, dose-escalation, adaptive...

​​​​​​Davide Bertoldo studied Pharmaceutical Biotechnology at the University of Padova (Italy) and University of Liège (Belgium). In 2012, he joined the Laboratory of Therapeutic Proteins and Peptides at EPFL (Switzerland). During his PhD, he developed peptide macrocycles targeting a variety of...

After obtaining my Master degree in Analytical chemistry at the University of RENNES – FRANCE in 2005. I always used mass spectrometry in the different laboratories I joined, starting at SERVIER for the structure elucidation of small molecules, then in a fundamental lab research facility in Paris...

José is a Science and People Lead in the Mass Spectrometry department of Large Molecule Research at Roche Pharma Research and Early Development (pRED). He leads large molecule drug discovery projects, from an initial concept to Phase I, and develops hands-on state of the art MS methods for...

A physician by training and an expert in immunobiology and drug development, Ezio Bonvini is the Senior Vice President of Research and Chief Scientific Officer at MacroGenics, Inc., which he joined in 2003 after a career at the National Cancer Institute, NIH, and the Center for Biologics Evaluation ...

Louis is the CSO and Management Board Member of JJP Biologics, an innovative new Polish Company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics around personalized medicine and companion diagnostics (JJP Biologics: Overview | LinkedIn). Louis...

Andrew Bradbury is Chief Scientific Officer of Specifica, a company he founded in 2016, after retiring from LANL. He trained in medicine at the Universities of Oxford and London and received his PhD from the University of Cambridge at the MRC Laboratory of Molecular Biology, under the guidance of...

Director Protein Science      Bioprocess & Analytical Development Germany  Responsible for the development of state-of-the-art purification processes for CMB client projects including process transfers to the global BioBU production network.Responsible for driving project independent...

Leigh, who holds a PhD in biochemistry and boasts over a decade of experience as a startup founder and operator, is an investor on the UCL Technology Fund life sciences team. The fund is a partnership between AlbionVC and UCL Business. It sees unique IP created at the London university spun...

In 2016, after receiving his PhD in Chemistry at the University of Strathclyde in Glasgow, Dan began working at MedImmune in Cambridge UK, where he utilised computational approaches for therapeutic protein design. In August of 2018, he joined Schrödinger as an Applications Scientist, where he now...

Dr. Qingyu Cao serves as the head of business development for GenScript ProBio CDMO services in Europe. She holds a PhD in Molecular Genetics and has more than 15 years’ experiences in biotech industry, CRO and CDMO space. Her knowledge and experiences expand from late discovery, to early...

Dr. Sara Carillo is the Bioanalytical Research Lead in the Characterisation and Comparability Laboratory in NIBRT, Ireland. Sara completed her PhD in Chemical Science at the University of Naples in 2013 working on bacterial glyco-conjugates structural characterisation. In 2015, Sara joined...

Dr Nicolas Lopez Carranza heads up the BioAI team at InstaDeep. He is also leading the development of DeepChain, an AI powered platform for protein Design. He has participated in several international conferences as a speaker in the domain of biotech and artificial intelligence. He is interested in ...

Samuele Cazzamalli studied Medicinal Chemistry at the University of Milan. During his doctoral studies at ETH Zürich in the group of Prof. Dario Neri (2015-2018), Samuele has generated novel Antibody-Drug Conjugate, Small Molecule-Drug Conjugate and Small Molecule-Radio Conjugate products for...

Krishna has completed his doctoral studies in the University of Zurich where he worked on establishing therapeutic and diagnostic potential of 2 anti-fibroblast activation protein (FAP) antibodies. This work was published in Clinical Cancer Research (part of AACR Journals). Krishna also went on...

Dr. Maggie Cheang is a Team Leader of the Genomic Analysis – Clinical Trials in Division of Clinical Studies and the Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU). Her research focus is to develop genomics classifiers for tumour subtypes and to determine their clinical ...

Svea Cheeseman is product manager at Refeyn. She holds a PhD in single-molecule biophysics and has 5 years’ experience in the biopharma industry working in product management and sales roles for different solution providers. She has a keen interest in pushing the boundaries of biomolecular analysis ...

Francis P. Crawley is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) and the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) located in Leuven, Belgium. Francis has expertise in EU, US, international and country-specific ethics, GCP, law, and...

I am currently a Senior Scientist at Amgen in the Therapeutic Area group, primarily working on developing bispecific antibodies and T cell engagers for immuno-oncology. Before Amgen, I was at Teneobio since July 2019 as Scientist III (and later Senior Scientist) in the Pre-Clinical Assays...

Biologist by training, I have 11 years of expertise in pharmaceutical company in the development of innovative therapies and diagnostic tools for Neurodegenerative Diseases. I started my career at AC Immune by characterizing vaccines and antibodies for Alzheimer’s and Huntington’s disorders. The...

Dr. Dimitrov graduated and completed his PhD at the University of Sofia, Sofia, Bulgaria, and thereafter he worked in the Bulgarian Academy of Sciences where he defended his ScD and was Professor of Biophysics until he joined the National Cancer Institute (NCI) of the National Institutes of Health...

A biochemist by training, Achim has been working with bispecific antibodies or ADCs and technology development for their effective screening. In one flavour, screening of such and further complex NBEs is realized applying versatile microfluidics and in part in conjunction with mammalian libraries...

Dr. Elena Dominguez Vega received her Ph.D. degree on analytical chemistry in 2011 at the University of Alcala (Spain). After joining the Biomolecular Analysis group at Utrecht University (The Netherlands) in 2012, she worked on the development of new electrophoretic methods for the analysis of...

Paul Dyer obtained his PhD in Cell Biology and Drug Delivery Strategies from the University of Greenwich. Following a period in academic research, Paul joined Halo Labs Ltd as an application scientist covering UK and Europe. Building upon his extensive background in medical science, he has been...

Christoph Esslinger is the CSO and scientific founder of Memo Therapeutics AG and a pioneer of the discovery of therapeutic antibody candidates directly from human donors for immunotherapy of Alzheimer’s Disease and cancer. Prior to founding Memo Therapeutics AG he held senior positions at CT...

Since October 2020, Dr. Andreas Evers is working as Computational and Structural Bioinformatician on NBEs at Merck Healthcare KGgaA. He obtained his PhD in Computational Chemistry with Prof. Gerhard Klebe at Philipps University of Marburg in 2000. He joined Sanofi in 2003, first working in the area ...

Maroua FERHAT is a Scientist at OncoOne, an innovative Austrian Biotech. With her expertise in immunology and cellular biology, she evaluates the therapeutical potential of anti-oxMIF antibodies in inflammatory diseases. Maroua received a PhD in Immunology from the University of Poitiers (Faculty...

I am an M.D., specialist in Oncology and Immunology, and I serve as a professor of Human Biochemistry at the School of Medicine, Federico II University of Naples, Italy. In the last decade, my research has provided significant contributions to the elucidation of the role of FK506 binding proteins...

FILLET Marianne, Pharmacist 1994 - 2010: Successively Research Fellow, Postdoctoral Researcher, Research Associate at the National Fund of Scientific Research (FNRS).2010-now: Professor, then Full professor at the University of Liege, Head of the Laboratory for the Analysis of Medicines...

Mark Fogg, Ph.D., is Director of Business Development at AbCellera. He brings over 25 years of scientific expertise in both academia and industry in the field of immunology. Following a PhD at the University of Reading in the UK defining T cell responses to respiratory syncytial virus, Mark moved...

Emma Foreman has been a hospital pharmacist for over 20 years, working in a variety of different hospitals from small district generals to large teaching hospitals – including a tiny mission hospital in Ghana. Taking on both technical and clinical roles, Emma specialised in oncology in 2001. She...

Founder and Managing Director of BioPlanta GmbH until the merger with Vita 34 AG in 2012, re-establishment of BioPlanta GmbH 2017. Chairman of the Management Board of Vita 34 AG 2012 to 2017. Management expertise in small and medium-sized biotech companies. Many years of experience in the field of...

Anne Goupil-Lamy, Ph.D., Science Council Fellow at BIOVIA, obtained her doctorate in Molecular Biophysics from the Sorbonne University, Paris.  She has been in charge of BIOVIA' contract research group for many years and today she is involved in many scientific collaborations with industrial...

Victor Greiff is an Associate Professor at the University of Oslo (Department of Immunology) since January 2018. His group develops machine learning, computational and experimental tools for analyzing antibody and T-cell repertoires to facilitate the in silico design of immune receptor-based...

I joined GSK on an apprentice program straight after finishing A Levels, the apprentice program included obtaining a BSc in Biological Sciences from the University of Kent. I have worked at GSK for almost 6 years, 3 years as an apprentice and 3 years as a full time employee. During my 6 years I...

Eliott is a Partner at Nodes Advisors where he leads investments at the cross section of biology, computer sciences and engineering.

Alice Harrison is currently Director, Global Technical & CMC, Analytics providing scientific and technical leadership to benefit customer programs. Alice studied chemistry at Queen Mary College (University of London - UK) and earned her DPhil in molecular immunology from University of Oxford in ...

Jana Hersch is part of the scientific team at Genedata with experience in both product development and scientific and technical communication. She is passionate about improving health with data and specializes in external and internal collaborations using different digital approaches and...

From April 1, 2022 Prof. René Hoet is Chief Innovation Officer at FairJourney Biologics with the focus on implementation of new innovative antibody discovery and optimization technologies.He obtained his PhD at the Un. Nijmegen, Netherlands (1988-1992) on autoantibodies and performed his...

Dr. Soraya Hölper works as a Lab Head for Mass Spectrometry for Sanofi in Frankfurt am Main. She is acquainted with the analysis of complex therapeutic antibodies within the Biologics Research division. After studying biochemistry at the Goethe University of Frankfurt am Main, Soraya did her...

Dr. Xiaoli Hu has over 15 years of experience in medical science and biotechnology industry, including business development, corporate strategy, venture capital investment and medical science research. She currently serves as Head of Business Development at Xbrane Biopharma AB, a global biosimilar...

I am leading the NIBR Biologics Center data management activities around data generation, capture and organization in close collaboration with our IT and external partners. In this role I am leading a global and cross-functional team of > 60 scientists.

Kristen Hurov, Ph.D. – I joined Bicycle Therapeutics in April 2018 and I am based at our US site in Lexington, MA. In my current role as Director, Oncology Research, my primary focus is to support the advancement of our immuno-oncology portfolio. As Program Leader, I’ve led the development of our...

Beat A. Imhof is professor and was chair of the Department of Pathology and Immunology for more than 10 years at the Medical Faculty, University of Geneva, Switzerland. He studied Biochemistry in Zurich, Switzerland, did then his PhD at the Friedrich Miescher Laboratory of the Max Planck Institute...

Sabine is a Principal Scientist at the Roche Innovation Center Munich in the Large Molecule Research Division since 2009. At Roche she has contributed as a scientist and technical project leader to several research and development projects in the disease areas of oncology, neurology and metabolic...

I graduated in 1989 from King´s College London with a Ph.D. in Biochemistry, followed by postdoctoral research in Wye College (University of London), then the University of Kent; the latter a joint project with the Advanced Centre for Biochemical Engineering at University College London. Following ...

Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem...

Dr. Sarah-Jane Kellmann works as a scientist as part of the R&D team at Bio-Rad AbD Serotec GmbH, which focusses on optimization of the monoclonal antibody generation platform. She studied biology at the University of Bonn and the Ruhr University Bochum, completing her master’s studies with an...

Dan Bach Kristensen holds a Ph.D. in biology and B.Sc. degree in chemistry. Dan is specialized in protein chemistry and mass spectrometry, which he initially applied in the field of proteome research in Japan and later in Denmark. For the last 15 years Dan has been working with analytical...

Dr. Mattias Levin has a MSc in Biotechnology and obtained his Ph.D. in Immunotechnology from Lund University. Since joining Alligator in 2015 his work has primarily been focused on the discovery of Alligators new antibody-based drug candidates and bringing them from the benchtop into the clinic. He ...

Dr. Qingcong Lin is SVP of Biocytogen and CEO of Biocytogen Boston Corporation. Dr. Lin focuses on Biocytogen’s global business development for antibody discovery services, RenMab/RenLite licensing and therapeutic antibody co-development, and on providing gene targeting services and humanized mouse ...

Anne Ljungars PhDSenior ResearcherTechnical University of DenmarkAnne Ljungars holds a PhD in Immunotechnology from Lund University, Sweden and has 20+ years of experience from biotech industry, latest from BioInvent International AB, Sweden where she has coordinated discovery efforts in several...

Robin Löving, Chief Scientific Officer (CSO) at Salipro Biotech. Robin has more than 15 years’ experience working with therapeutically interesting membrane proteins. He did his PhD with a focus on membrane proteins and antigen design at the Karolinska Institute in Stockholm, Sweden. After being...

Ana Lujan is a Bioinformatics Scientist at Twist Biopharma in the Technology Development group. She completed her undergraduate degrees in Biochemistry and Biophysics at the University of Pennsylvania.  She was a member of the Quantum Engineering Laboratory and participated in a project focused on...

Andrea Marschall studied Molecular Biotechnology at Heidelberg University, gained a PhD in Stefan Dübel's lab on targeting antibodies into living cells, continuing with Postdoctoral research at the Helmholtz Centre for Infection Research in Braunschweig (Germany) and at Brandeis University in...

Fionnuala received her PhD (Microbiology) from Trinity College Dublin in 2002.  Her post-doctoral studies were carried out at Wyeth Pharmaceuticals (NY) where she worked on S. aureus antibiotic resistance mechanisms.  She then transferred to the Global Biologics organization at Wyeth...

Enkelejda's research at the School of Life Sciences FHNW focuses on the use of computer science and artificial intelligence for drug discovery and personalized medicine. In doing so, she has a bridge function that is intended to link different life sciences processes with computer science.

Dr. Michel Mikhail has more than 30 years Pharmaceutical Industry experience and track record of achievement in R & D and International Regulatory Affairs in large multinational Research-based pharmaceutical Companies. He also has a global experience and significant contribution in Biotech...

Dr Peter Molloy is currently a Director of Protein Science Research at Immunocore Ltd, where he has worked for the past twenty tears. He runs a group that develops and improves the technology for generating and screening TCR-based immunotherapeutics. He has contributed significant advances to the...

2006 – 2010 Study (Biological Chemistry) at Mannheim University of Applied Sciences (Germany) 2011 –2014  PhD Study (Biotechnology, summa cum laude) at Institute for Medical Technology of University Heidelberg and Mannheim University of Applied Sciences (Germany) (CeMOS)• Topic: “Analysis of...

Drazen Nadoveza received his PhD in 2014 in the Laboratory for Computer-Aided Design and Production (LICP) of the Swiss Federal Institute of Technology in Lausanne (EPFL). His major research interests include: context-aware systems, software architectures and bioinformatics. He is a tech lead of...

My research group is focused on protein engineering of calcium binding proteins for biotechnological applications. We apply structural biology analysis, proteomics tools and biophysical methods to develop new technology and our work is aimed at improving the molecular toolbox available to...

Benjamí Oller-Salvia is Assistant Professor at IQS School of Engineering ? Ramon Llull University in Barcelona (Spain). He obtained his PhD at the University of Barcelona, conducting research in Prof. Ernest Giralt?s laboratory at the Institute for Research in Biomedicine (IRB Barcelona). His PhD...

I’m currently a PhD student in Immunoinformatics at the Oxford Protein Informatics Group (OPIG), University of Oxford. I’m funded via the EPSRC Sustainable Approaches to Biomedical Science Centre for Doctoral Training: Responsible and Reproducible Research (SABS:R3) program. My research interests...

Curious by and about Nature; this is my journey. Fascinated about the mechanisms of life, I started with a degree in Biochemistry and Molecular Biology at the University of Barcelona, followed by a Masters in Biotechnology and a PhD in Biochemistry and Molecular Biology at IRBB. My scientific...

Working in the Biopharm Discovery department in the High Throughput Characterisation team, my main role is to characterise potential therapeutic antibodies on their biophysical properties throughout the drug discovery process from 100’s of molecules down to one candidate. My main technical...

Raj is a Medical Doctor, Professor, Technology Futurist, Serial Entrepreneur, International Healthcare Volunteer & renowned Global Speaker -practicing ‘Healthcare Democratization’ by supporting disruptive Life sciences initiatives globally that can impact the planet.A globetrotter, with close...

Isidoros Papaioannou holds a MSc degree in Statistics from the University of Manchester and a PhD degree in Epidemiology from the Swiss Tropical and Public Health Institute.After his studies, he joined PricewaterhouseCoopers as a data science consultant, where he worked in the area of Real-World...

Claudio Pasqual has worked with the Waters consumables group for 16 years looking after HPLC, UPLC and sample preparation technologies. He now works as Specialist for the Biopharmaceutical Market in Switzerland for biopharma applications such as protein analysis, characterization of complex...

Dr. Ravish Patel is currently a Senior Manager- I at Sun Pharmaceuticals Ltd. in the Pharmacology and Bioassay Group. Before joining Sun Pharmaceuticals in 2021, He served Wockhardt Biotech, Cipla, Cadial, and Intas Biotech in different capacities. Ravish has about 14 years of experience in the...

Dhaval Patel leads UCB's research organization with the main goal of bringing scientific innovation to patients and helping them live the life they choose.

Lukas Pekar graduated his PhD studies in Biochemistry at the Technical University of Darmstadt in the group of Prof. Dr. Harald Kolmar in 2020, primarily working on protein engineering for immune cell recruitment and especially on possibilities for NK cell redirection via bispecific antibodies and...

Niccolò Pengo joined Mabylon in March 2019. He holds a PhD from the San Raffaele University in Milan with studies on B-cell immunology and worked as a post-doctoral fellow at University College London and as a Senior Scientist at UCB Pharma in the UK. During his research both in academia and...

Laurent Poirot is an immunologist with over 13 years of experience in biotech. In graduate school, he studied immunology in the laboratory of Diane MATHIS and Christophe BENOIST (Université de Strasbourg, France and Harvard Medical School, Boston, MA). His PhD thesis focused on the pathogenic...

Martyna joined Mink Therapeutics in April 2019. She works as part of the R&D team, developing modified iNKT cells for cancer therapy. She contributed to the advancement of the innovative CAR discovery platform. As a project lead, she coordinated Mink’s first solid tumor targeting project. She...

Johannes Preiner is a research group leader at the University of Applied Sciences Upper Austria and a lecturer at the Johannes Kepler University (JKU) of Linz (Austria). He obtained his PhD at the Institute of Biophysics at JKU working in the group of Prof. Peter Hinterdorfer on various atomic...

Dr. Reichert, Executive Director of The Antibody Society, is an internationally-recognized expert in the development of antibody and peptide therapeutics. She is Founder and Managing Director of Reichert Biotechnology Consulting LLC, a biopharmaceutical business intelligence research firm, and...

> Since 2017: Lab Head of mass spectrometry lab within Analytical Development of Biologicals (Boehringer Ingelheim, Biberach, Germany)      Mass spectrometric characterization of Biologicals, establishment of structure-function-relationships > 2014-2017: Scientist at “Physikalisch-Technische...

I’m currently a 2nd year PhD student in Prof. Vijay Chudasama group at UCL where I am working on the development of pyridazinedione for the generation of novel protein-based conjugates. I have carried out my undergraduate and master studies in France, in the engineering school CPE Lyon, with a...

I am heading a research group at the department of Protein science at the KTH School of Engineering sciences in Chemistry, Biotechnology and Health. We are a young group with four great PhD students, two excellent technicians, one extraordianary fantastic labmanager and two researchers. Our...

Nicolas Sabarth is heading a biotherapeutics discovery group at Boehringer-Ingelheim Vienna, Austria. He received his PhD from the Max-Planck-Institute for Infection Biology, Germany.  Since then, he held positions of increasing responsibility in the R&D departments of...

Rune did his PhD on ion mobility mass spectrometry at University of Southern Denmark in a collaboration with Novo Nordisk and graduated in 2012. Since then he has worked in therapeutic protein and antibody discovery research focusing on biophysical characterization and developability. In 2018 he...

Dr. Thomas Schirrmann is CEO of YUMAB and COO of Corat Therapeutics. He is biochemist by training and holds a PhD in immunology. He has more than 20 years expertise in research for immunotherapies and antibody technologies and published 70+ scientific articles. Thomas is co-founder and CEO of...

Philip is the Chair of the International Advisory Board for the Alliance for Safe Biologic Medicines, which serves as an authoritative resource center of information for the public, as well as the healthcare and health policy communities, on the issues surrounding biologic medications.  Professor...

Dr. Schnitzer, M.D. has devoted more than 30 years to understanding vascular endothelial cell barrier function and drug delivery in medicine, specifically how best to overcome this barrier to improve therapeutic impact of drugs in cancer, lung and other diseases. His lab currently focuses on drug...

Markus Seeger is Associate Professor at the Institute of Medical Microbiology at the University of Zurich. The Seeger lab applies protein engineering to understand transport processes in pathogenic bacteria at the molecular level. The sybody (synthetic nanobody) platform is instrumental to trap...

Peter Senter joined Seattle Genetics in August 1998 and has served as Vice President, Chemistry since September 2002. In February 2009, Dr. Senter was recognized as the company's first Distinguished Fellow. He leads Seattle Genetics' chemistry department, which carries out research in...

Leah is a co-founder and VP and Head of Therapeutic Discovery at 3T Biosciences.  At 3T she leads the R&D operations and strategy focusing on identifying new immunotherapy targets, and engineering T cell receptor based therapeutics. Leah has co-authored work in high-impact journals such as...

Dr Marcin J. Skwark is the Bioinformatics Lead at InstaDeep Ltd. Before joining InstaDeep in the beginning of 2020, he conducted academic research in computational structural biology at universities in Stockholm (Stockholm University), Helsinki (Aalto University), Beijing (Tsinghua...

After completing his doctoral work in 2016 at Arizona State University in biochemistry, Dayn joined KBI Biopharma as an analytical scientist supporting CMC service offerings. He then transitioned into BD operations, growing KBI’s analytical and manufacturing business for 3 years. At Similis, his...

Gunther is the co-founder and Chief Scientific officer of Elthera AG, a startup company developing therapeutic antibodies for the treatment of cancer. He has long-standing experience as leader of early drug development projects in the field of therapeutic antibodies and vaccines as well as...

Philipp Spycher is the co-founder and CEO of Araris Biotech AG. Philipp incorporated Araris after winning the PSI Founder Fellowship as well as several other prices and grants to commercialize the Araris Linker Technology. During his post-doctoral work at the Paul Scherrer Institute...

Dr. Ankita Srivastava is a Protein Biochemist who has more than 15 years of combined industry and academic experience in both large and small molecule drug discovery. She is currently VP of Protein Sciences and Rational Design in the Antibody Engineering Department at Ichnos...

Anish Suri is an immunologist with extensive experience in basic and translational research focused on immuno-oncology, autoimmune disorders, transplantation rejection, and inflammation. Prior to joining Cue Biopharma, he held roles of increasing responsibility at Janssen Pharmaceutical...

Tanaya Surve is a Senior Scientist in the Bioproduction group at Horizon Discovery, a Perkin Elmer Company. With over 11 years of experience in cell line development, Tanaya has contributed to the drug product development and launch of several molecules of therapeutic importance. Her current role...

Doctoral thesis on development of alternative protein production systems based on CHO cell lysates at Berlin University for Technology and Fraunhofer IZI-BB; Followed by 2 years Post Doc at Fraunhofer IZI-BB managing diverse research and customer projects related to production of...

Greg M. Thurber is an Assistant Professor of Chemical Engineering and Biomedical Engineering at the University of Michigan. His work focuses on applying fundamental biotransport principles to design novel therapeutics and molecular imaging agents. These widely applicable techniques have found use...

Dr Isabelle Turbica serves as Assistant Professor in Biotechnology, at the School of Pharmacy of Paris-Saclay University since 2002, with skills that focus on therapeutic protein engineering and production. In particular, she is in charge of the Master degree “Pharmaceutical biotechnology and...

I am a Marie sklodowska-Curie PhD candidate at the University of Strasbourg (BFC Lab, FR), carrying out the scientific activity in the frame of the Targeted-Anticancer Therapies (TACT) European project. My research is focused on the ADCs area and its aim is set to the synthesis and evaluation of...

As head of the Immunomonitoring Services Lab of Sanquin Diagnostic Services, Annelies has led many investigations implementing various cellular assays to support (pre-) clinical studies. Supported by a team of PhD Scientists and Technicians the Immunomonitoring Services Lab specializes in using...

Paul van Bergen en Henegouwen studied biology at the University of Amsterdam and received his PhD in 1986 at the Utrecht University. Postdoctoral training was performed at the Utrecht University in the group of prof. Dr. A.J. Verkleij, in Toulouse, France in the group of prof. dr. H. Chap, ISERM...

Marjolein van Egmond's laboratory studies antibody activation of innate myeloid immune cells, macrophages and neutrophils, with emphasis on understanding the role of immunoglobulin A (IgA) in physiology and pathology. Her groups research focuses specifically on (1) the contribution of abnormal...

Éric Vivier, DVM, PhD, is Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille (AP-HM). In addition, he was appointed in 2018, Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic...

Dr. Alain Wagner is director of the Bio-Functional Chemistry team (BFC, www.biofunctional.eu) part of the Research Unit 7199 at the University of Strasbourg. He is a recognized expert in the fields of biofunctional chemistry. Alain is the author of 152 publications and the inventor of 27 patents, 8 ...

Adrian is currently a Senior Director at Bright Peak Therapeutics leading the Autoimmune Disease team to develop half-life extended synthetic cytokines and immunocytokines that have been engineered to selectively expand regulatory T cells. Prior to this, he has held positions at Novartis, Glenmark...

10 years’ experience in sales and strategic marketing in the biotech & med-tech industry helping you to grow the topline revenue through enlarging customer bases & increasing “share of market” and” share of wallet” at customers; further to penetrate the market by increasing the visibility...

The Ward laboratory is run jointly with the laboratory of Professor Raimund Ober. The research is directed towards taking a highly interdisciplinary approach to generate effective therapeutics for autoimmunity and cancer. This involves a combination of antibody/protein engineering, fluorescence...

Jaap Wieling brings 30 years of experience as an executive and entrepreneur in biopharmaceutical research and development. He fulfills executive, board and advisor positions in startup biotech companies and (pharmaceutical) service industries since 1999. Before that he held executive and research...

Thomas Wiese serves Roche in the role of a Principal Medical Director and Clinical Expert Team Leader. He is a board certified Pediatric Psychiatrist with 7 years of experience in clinical practice, clinical research and 6 years in pharmaceutical clinical drug development. Thomas is also trained...

Dr. Gillian Woollett joined Samsung Bioepis in November 2021 as VP, Head Regulatory Strategy and Policy, US (SBUS), to stand up a US presence for science-based regulatory strategy and policy in the leading global market for biologics, including but not limited to biosimilars.Prior to this recent...

Dr. Gordana Wozniak Knopp has received her PhD in Biochemistry and Molecular Biology from Medical University of Ljubljana, Slovenia. In her post-doctoral studies at the University of Natural Resources and Life Sciences (BOKU), Vienna, she got acquainted with display library methods and development...

Jens Wuerthner is a physician scientist and currently holds the position of Head of Clinical Development EU for ADC Therapeutics in Lausanne, Switzerland. He is a licensed physician in Germany, Switzerland and the UK and a fellow of the Faculty of Pharmaceutical Medicine, UK. Dr. Wuerthner...

David has more than 10 years’ experience in research, with the last 5 years working in antibody discovery. Having first trained in structural biology at the University of Oxford, he then developed expertise in antibody discovery and next generation sequencing technologies while working at Crescendo ...

Jared is a dedicated analytical scientist, leveraging a combination of scientific expertise and computer science skills to extract as much value as possible from analytical efforts. He completed his B.S. in Chemical and Biological Engineering at the University of Colorado with a thesis on directed ...

Stefan received his PhD in 2015 from the Technische Universität of Darmstadt, Germany, where he worked in the Group of Harald Kolmar in the field of protein engineering of non-canonical antibodies. During his PhD he spent some time at Scripps Institute, La Jolla (USA) working in the lab of Vaughn...

Iwan Zimmermann is one of the founders and Chief Scientific Officer of Linkster Therapeutics. Iwan has over 12 years of experience with single domain antibodies and the biology of ion channels and transporters. Prior to co-founding Linkster Therapeutics, Iwan conducted research as platform leader...